Osteoporosis International

, Volume 23, Issue 11, pp 2577–2577

Erratum to: Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper

  • R. Rizzoli
  • J. J. Body
  • A. DeCensi
  • J. Y. Reginster
  • P. Piscitelli
  • M. L. Brandi
  • on behalf of the European Society for Clinical and Economical aspects of Osteoporosis and Osteoarthritis (ESCEO)
Erratum

DOI: 10.1007/s00198-012-1930-0

Cite this article as:
Rizzoli, R., Body, J.J., DeCensi, A. et al. Osteoporos Int (2012) 23: 2577. doi:10.1007/s00198-012-1930-0
  • 404 Views

Erratum to: Osteoporos Int

DOI 10.1007/s00198-011-1870-0

The third author’s name was rendered incorrectly. The correct name is A. DeCensi.

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2012

Authors and Affiliations

  • R. Rizzoli
    • 1
  • J. J. Body
    • 2
  • A. DeCensi
    • 3
    • 4
  • J. Y. Reginster
    • 5
  • P. Piscitelli
    • 6
  • M. L. Brandi
    • 6
  • on behalf of the European Society for Clinical and Economical aspects of Osteoporosis and Osteoarthritis (ESCEO)
  1. 1.Division of Bone DiseasesGeneva University Hospitals and Faculty of MedicineGenevaSwitzerland
  2. 2.Department of Medicine, CHU BrugmannUniversité Libre de BruxellesBrusselsBelgium
  3. 3.Division of Medical OncologyGalliera HospitalGenoaItaly
  4. 4.Division of Cancer Prevention and GeneticsEuropean Institute of OncologyMilanItaly
  5. 5.Department of Public Health ScienceUniversity of LiègeLiègeBelgium
  6. 6.Department of Internal MedicineUniversity of FlorenceFlorenceItaly